Immune Checkpoint Inhibitors Market is Expected to Register a Considerable Growth by 2026
The Immune Checkpoint Inhibitors Market is likely to rebound at a significant CAGR of 18.2%. The global market for immune checkpoint inhibitors (ICIs) was growing at a rapid pace and was expected to continue its upward trajectory in the coming years. ICIs are a type of cancer immunotherapy that work by blocking the signals that cancer cells use to evade the immune system.